1Centers for Disease Control and Prevention CDC. Staphylococcus aureus resistant to vancomycin-United States, 2002. MMWR Morb Mortal Wkly Rep, 2002, 51(26): 565-567.
2Centers for Disease Control and Prevention CDC, Vancomyein-resistant Staphylococcus aureus-Pennsylvania, 2002. MMWR Morb Mortal Wkly Rep, 2002, 51(40): 902.
3Centers for Disease Control and Prevention CDC. Vancomyein resistant Staphylococcus aureus-New York, 2004. MMWR Morb Mortal Wkly Rep, 2004, 53(15): 322-323.
4Tenover FC, Weigel LM, Appelbaum PC, et al. Vancomycin-resistant Staphylococcu,s aureus isolate from a patient in Pennsylvania. Antimicrob Agents Chemother, 2004, 48(1): 275-280.
5Fridkin SK, Hageman J, McDougal LK,et al. Epidemiological and microbiological characterization of infections caused by Staphylococcus aureus with reduced susceptibility to vancomycin, United States, 1997 2001, Clin Infect Dis, 2003,36(4): 429-439.
6Moore MR, Perdreau-Remington F, Chambers HF. Vaneomyein treatment failure associated with heterogeneous vancomycin-intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis. Antimicrob Agents Chemother,2003, 47(4): 1262-1266.
7Marchese A, Balistreri G, Tonoli E, et al. Heterogeneous vancomycin resistance in methicillin-resistant Staphylococcus aureus strains isolated in a large Italian hospital. J Clin Microbiol, 2000,38(2): 866-869.
8Kim MN, Hwang SH, Pyo YJ, et al. Clonal spread of Staphylococcus aureus heterogeneously resistant to vancomycin in a university hospital in Korea. J Clin Microbiol, 200?, 40(4): 1376-1380.
9Cui L, Ma X, Sato K, et al. Cell wall thickening is a common feature of vancomycin resistance in Staphylococcus aureus. J Clin Microbiol, 2003, 41(1): 5-14.
10Cui L, Murakami H, Kuwahara-Arai K, et al. Contribution of a thickened cell wall and its glutamine nonamidaled component to the vancomycin resistance expressed by Staphylococcus aureus Mu50. Antimicrob Agents Chemother, 2000, 44(9): 2276-2285.
